Microarray analysis in a cell death resistant glioma cell line to identify signaling pathways and novel genes controlling resistance and malignancy.

Cancers (Basel) 2011 Jun 27;3(3):2827-43. Epub 2011 Jun 27.

Laboratory of Molecular Neuro-Oncology, Department of General Neurology, Hertie-Institute for Clinical Brain Research and Center Neurology, University of Tuebingen, Otfried-Mueller-Str. 27, Tuebingen 72076, Germany.

Glioblastoma multiforme (GBM) is a lethal type of cancer mainly resistant to radio- and chemotherapy. Since the tumor suppressor p53 functions as a transcription factor regulating the expression of genes involved in growth inhibition, DNA repair and apoptosis, we previously assessed whether specific differences in the modulation of gene expression are responsible for the anti-tumor properties of a dominant positive p53, chimeric tumor suppressor (CTS)-1. CTS-1 is based on the sequence of p53 and designed to resist various mechanisms of inactivation which limit the activity of p53. To identify CTS-1-regulated cell death-inducing genes, we generated a CTS-1-resistant glioma cell line (229R). We used Affymetrix whole-genome microarray expression analysis to analyze alterations in gene expression and identified a variety of CTS-1 regulated genes involved in cancer-linked processes. 313 genes were differentially expressed in Adeno-CTS-1 (Ad-CTS-1)-infected and 700 genes in uninfected 229R cells compared to matching parental cells. Ingenuity Pathway Analysis (IPA) determined a variety of differentially expressed genes in Ad-CTS-1-infected cells that were members of the intracellular networks with central tumor-involved players such as nuclear factor kappa B (NF-κB), protein kinase B (PKB/AKT) or transforming growth factor beta (TGF-β). Differentially regulated genes include secreted factors as well as intracellular proteins and transcription factors regulating not only cell death, but also processes such as tumor cell motility and immunity. This work gives an overview of the pathways differentially regulated in the resistant versus parental glioma cells and might be helpful to identify candidate genes which could serve as targets to develop novel glioma specific therapy strategies.

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers3032827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759173PMC
June 2011

Publication Analysis

Top Keywords

genes
9
glioma cell
8
differentially regulated
8
differentially expressed
8
tumor suppressor
8
gene expression
8
regulated genes
8
genes involved
8
cell death
8
cell
6
cells compared
4
229r cells
4
cells
4
uninfected 229r
4
700 genes
4
adeno-cts-1 ad-cts-1-infected
4
genes uninfected
4
ad-cts-1-infected 700
4
expressed adeno-cts-1
4
parental cells
4

Similar Publications